We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$29.8M
Cap. Flow
-$1.17B
Cap. Flow %
-4.59%
Top 10 Hldgs %
14.11%
Holding
1,418
New
109
Increased
422
Reduced
606
Closed
147

Top Buys

Rank Stock Value
1
JMIA
Jumia Technologies
JMIA
+$130M
2
NXPI icon
NXP Semiconductors
NXPI
+$55.3M
3
AZO icon
AutoZone
AZO
+$42.3M
4
ALC icon
Alcon
ALC
+$35.7M
5
INTU icon
Intuit
INTU
+$33.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$126M
2
BIDU icon
Baidu
BIDU
+$83.8M
3
ROK icon
Rockwell Automation
ROK
+$76.1M
4
AMZN icon
Amazon
AMZN
+$74.9M
5
XLNX
Xilinx Inc
XLNX
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 15.25%
3 Consumer Discretionary 10.67%
4 Financials 10.37%
5 Industrials 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIC
1351
DELISTED
Retail Opportunity Investments Corp.
ROIC
-251,890
Closed -$4.37M
CDMO
1352
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-21,956
Closed -$93K
SRCL
1353
DELISTED
Stericycle Inc
SRCL
-11,800
Closed -$642K
CONN
1354
DELISTED
Conn's Inc.
CONN
-19,100
Closed -$437K
EVBG
1355
DELISTED
Everbridge, Inc. Common Stock
EVBG
-5,100
Closed -$383K
IMGN
1356
DELISTED
Immunogen Inc
IMGN
-30,744
Closed -$83K
ICPT
1357
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-29,755
Closed -$3.33M
RETA
1358
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-4,800
Closed -$410K
WWE
1359
DELISTED
World Wrestling Entertainment
WWE
-61,050
Closed -$5.3M
RUTH
1360
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-8,700
Closed -$223K
PZN
1361
DELISTED
Pzena Investment Management, Inc. Class A
PZN
-19,200
Closed -$155K
GBL
1362
DELISTED
GAMCO Investors, Inc.
GBL
-22,100
Closed -$453K
CTT
1363
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
-33,164
Closed -$326K
TVTY
1364
DELISTED
Tivity Health, Inc. Common Stock
TVTY
-36,500
Closed -$641K
ANAT
1365
DELISTED
American National Group, Inc. Common Stock
ANAT
-17,709
Closed -$2.14M
SRGA
1366
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-5,492
Closed -$990K
SUNS
1367
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
-14,100
Closed -$242K
ZIXI
1368
DELISTED
Zix Corporation
ZIXI
-21,400
Closed -$147K
ADMS
1369
DELISTED
Adamas Pharmaceuticals
ADMS
-186,701
Closed -$1.33M
ECHO
1370
DELISTED
Echo Global Logistics, Inc.
ECHO
-10,000
Closed -$248K
BPFH
1371
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
-30,800
Closed -$338K
STAY
1372
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
-249,700
Closed -$4.48M
CLGX
1373
DELISTED
Corelogic, Inc.
CLGX
-15,100
Closed -$563K
ZAGG
1374
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-10,600
Closed -$96K
EIGI
1375
DELISTED
Endurance International Group Holdings, Inc.
EIGI
-120,971
Closed -$877K

Similar funds

Axa's Q2 2019 Portfolio in Review

As of Q2 2019, Axa held 1,418 positions worth $25.6B, up 0.12% from $25.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $1.17B in Q2 2019, closing 147 positions and reducing 606 holdings. Its most notable exit was Foot Locker, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Jumia Technologies worth $119M.

  • Axa's largest Q2 2019 buy was Jumia Technologies: 4,502,527 shares worth $119M.
  • Axa added most to NXP Semiconductors in Q2 2019, an estimated $55.3M increase.
  • Axa's biggest Q2 2019 reduction was Linde, cutting an estimated $126M.
  • Axa fully exited Foot Locker in Q2 2019, selling an estimated $10.1M.
  • Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q2 2019.
  • Axa opened 109 new positions and closed 147 in Q2 2019.
  • Axa's portfolio value rose 0.12% quarter-over-quarter to $25.6B.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.